Bulletin
Investor Alert

Europe Markets Archives | Email alerts

Sept. 22, 2023, 7:22 a.m. EDT

JPMorgan says the coming energy crisis may be worse than what Europe experienced

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Crude Oil WTI (NYM $/bbl) Front Month (CL.1)
  • X
    ENI S.p.A. (ENI)
  • X
    Shell PLC (SHEL)

or Cancel Already have a watchlist? Log In

By Steve Goldstein

JPMorgan on Friday pounded the table for energy stocks, as higher-for-longer interest rates further squeezes the flow of capital into new supply.

Europe’s energy stocks XX:SXEP have only gained 10% since June while oil prices /zigman2/quotes/211629951/delayed CL.1 +0.33% have jumped 30%. JPMorgan said it’s recommending the majors over midcaps, upgrading Eni /zigman2/quotes/209584888/delayed IT:ENI +1.48% to overweight, reiterating overweights on Shell /zigman2/quotes/206428183/delayed UK:SHEL +0.44% , TotalEnergies /zigman2/quotes/206172043/delayed FR:TTE +0.05% and Neste /zigman2/quotes/202009726/delayed FI:NESTE -0.39% , and lifting Repsol /zigman2/quotes/202941606/delayed ES:REP -0.19% to neutral. The bank raised its rating on global energy stocks to overweight from neutral, as it sees an emerging supply-demand gap beyond 2025, coupled with strengthening sector fundamentals.

Globally, it said the key stocks to outperform are Eni, Shell, TotalEnergies, Saudi Aramco SA:2222 -0.58% , Exxon Mobil /zigman2/quotes/204455864/composite XOM +0.16% , Marathon Petroluem /zigman2/quotes/209634297/composite MPC -0.85% , Tenaris /zigman2/quotes/209486716/composite TS -0.42% , Baker Hughes /zigman2/quotes/205323712/composite BKR +0.97% , Cenovus /zigman2/quotes/207955267/delayed CA:CVE +0.26% , Prio , PetroChina /zigman2/quotes/206980083/delayed CN:601857 +1.50% , Beach Energy /zigman2/quotes/200513631/delayed AU:BPT +0.31% and Ampol /zigman2/quotes/207954233/delayed AU:ALD +2.11% .

“Dear generalists, put your seatbelts on,” said analysts led by Christyan Malek. “While we believe the sector is in a structural up-cycle and oil should normalize higher, we expect prices and by extension energy equities to trade in a wider range, discounting an effective higher weighted average cost of capital associated with elevated price volatility and concerns around ESG/peak demand.”

The analysts do not share the peak demand fears, at least on its investment horizon that runs through 2030, saying the clean energy system is not mature enough to capture and distribute to end customers. “As a result, this places greater pressure on traditional fuels to fill the gap and meet rising EM-led demand growth. However, without increasing oil and gas capex, we risk energy deficits and acute inflation across the commodities complex.”

“This may lead to multiple oil-led energy crises in this decade, potentially much more severe than the gas crisis seen in Europe in 2022. Moreover, it serves to position OPEC firmly at the steering wheel of the global oil market, to take greater share of demand growth, while helping mitigate sharp price moves in either direction.”

One interesting note is that the analysts do not find oil prices in the $100-to-$120 range to be demand destructive, as it would still imply oil’s share of the world economy below 4%.

Friday saw a catching down of European stocks to the sharp decline on Thursday on Wall Street, even though U.S. stock futures pointed to a stronger start.

The U.K. FTSE 100 UK:UKX rose 0.6% while the German DAX DX:DAX fell 0.1% and the French CAC 40 FR:PX1 lost 0.5%.

Ubisoft Entertainment shares /zigman2/quotes/200990331/delayed FR:UBI +4.47% rose 4% after the U.K. competition regulator provisionally blessed the Microsoft-Activision deal that would see the French video games maker get cloud rights to Activision /zigman2/quotes/200717283/composite ATVI +1.70% games.

AstraZeneca stock /zigman2/quotes/203048482/delayed UK:AZN +1.47% added 2% as it and partner Daiichi Sankyo said a Phase III trial of a breast cancer drug showed statistically significant progression-free survival benefit. “This was another pivotal readout for [datopotamab deruxtecan] and could reinvigorate sentiment about this drug’s broader potential to replace systemic chemotherapy across a range cancers whilst also providing another important read on safety,” said Dr. Sean Conroy, an analyst at Shore Capital.

/zigman2/quotes/211629951/delayed
US : U.S.: Nymex
$ 90.33
+0.30 +0.33%
Volume: 379,104
Sept. 22, 2023 4:59p
loading...
/zigman2/quotes/209584888/delayed
IT : Italy: Milan
15.24
+0.22 +1.48%
Volume: 15.18M
Sept. 22, 2023 5:45p
P/E Ratio
5.77
Dividend Yield
6.20%
Market Cap
€50.94 billion
Rev. per Employee
€3.58M
loading...
/zigman2/quotes/206428183/delayed
UK : U.K.: London
2,607.50 p
+11.50 +0.44%
Volume: 9.51M
Sept. 22, 2023 4:35p
P/E Ratio
7.63
Dividend Yield
3.61%
Market Cap
£172.86 billion
Rev. per Employee
£3.04M
loading...
/zigman2/quotes/206172043/delayed
FR : France: Euronext Paris
61.91
+0.03 +0.05%
Volume: 3.66M
Sept. 22, 2023 5:55p
P/E Ratio
8.30
Dividend Yield
4.70%
Market Cap
€150.62 billion
Rev. per Employee
€2.26M
loading...
/zigman2/quotes/202009726/delayed
FI : Finland: Helsinki
35.42
-0.14 -0.39%
Volume: 1.61M
Sept. 22, 2023 6:29p
P/E Ratio
23.76
Dividend Yield
2.88%
Market Cap
€27.20 billion
Rev. per Employee
€4.38M
loading...
/zigman2/quotes/202941606/delayed
ES : Spain: Madrid
15.62
-0.03 -0.19%
Volume: 14.20M
Sept. 22, 2023 5:38p
P/E Ratio
6.65
Dividend Yield
1.94%
Market Cap
€19.78 billion
Rev. per Employee
€2.75M
loading...
SA : Saudi Arabia Stock Exchange
ر.س.‏ 34.10
-0.20 -0.58%
Volume: 15.36M
Sept. 21, 2023 12:00a
P/E Ratio
16.25
Dividend Yield
5.34%
Market Cap
ر.س.‏8248.71 billion
Rev. per Employee
ر.س.‏28.50M
loading...
/zigman2/quotes/204455864/composite
US : U.S.: NYSE
$ 114.94
+0.18 +0.16%
Volume: 13.20M
Sept. 22, 2023 4:02p
P/E Ratio
9.19
Dividend Yield
3.17%
Market Cap
$460.13 billion
Rev. per Employee
$5.82M
loading...
/zigman2/quotes/209634297/composite
US : U.S.: NYSE
$ 153.46
-1.31 -0.85%
Volume: 2.81M
Sept. 22, 2023 4:00p
P/E Ratio
5.57
Dividend Yield
1.95%
Market Cap
$61.36 billion
Rev. per Employee
$8.80M
loading...
/zigman2/quotes/209486716/composite
US : U.S.: NYSE
$ 30.99
-0.13 -0.42%
Volume: 1.88M
Sept. 22, 2023 4:00p
P/E Ratio
4.99
Dividend Yield
0.00%
Market Cap
$18.45 billion
Rev. per Employee
$585,604
loading...
/zigman2/quotes/205323712/composite
US : U.S.: Nasdaq
$ 35.40
+0.34 +0.97%
Volume: 5.01M
Sept. 22, 2023 4:00p
P/E Ratio
31.24
Dividend Yield
2.26%
Market Cap
$35.74 billion
Rev. per Employee
$423,727
loading...
/zigman2/quotes/207955267/delayed
CA : Canada: Toronto
$ 26.64
+0.07 +0.26%
Volume: 4.96M
Sept. 22, 2023 4:00p
P/E Ratio
13.59
Dividend Yield
2.27%
Market Cap
$50.52 billion
Rev. per Employee
$9.34M
loading...
/zigman2/quotes/206980083/delayed
CN : China: Shanghai
¥ 8.11
+0.12 +1.50%
Volume: 111.14M
Sept. 22, 2023 3:00p
P/E Ratio
9.75
Dividend Yield
5.30%
Market Cap
¥1427.62 billion
Rev. per Employee
¥7.43M
loading...
/zigman2/quotes/200513631/delayed
AU : Australia: Sydney
$ 1.63
+0.0050 +0.31%
Volume: 5.89M
Sept. 22, 2023 4:10p
P/E Ratio
9.25
Dividend Yield
2.46%
Market Cap
$3.70 billion
Rev. per Employee
N/A
loading...
/zigman2/quotes/207954233/delayed
AU : Australia: Sydney
$ 33.40
+0.69 +2.11%
Volume: 982,419
Sept. 22, 2023 4:10p
P/E Ratio
56.82
Dividend Yield
5.99%
Market Cap
$7.96 billion
Rev. per Employee
$4.23M
loading...
/zigman2/quotes/200990331/delayed
FR : France: Euronext Paris
29.44
+1.26 +4.47%
Volume: 439,676
Sept. 22, 2023 5:55p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
€3.73 billion
Rev. per Employee
€90,116
loading...
/zigman2/quotes/200717283/composite
US : U.S.: Nasdaq
$ 93.92
+1.57 +1.70%
Volume: 19.82M
Sept. 22, 2023 4:00p
P/E Ratio
34.35
Dividend Yield
1.05%
Market Cap
$73.90 billion
Rev. per Employee
$669,692
loading...
/zigman2/quotes/203048482/delayed
UK : U.K.: London
11,046.00 p
+160.00 +1.47%
Volume: 2.40M
Sept. 22, 2023 4:35p
P/E Ratio
33.77
Dividend Yield
2.12%
Market Cap
£171.20 billion
Rev. per Employee
£442,743
loading...

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.